Literature DB >> 20015292

Structure-function relationships of the N-terminus of receptor activity-modifying proteins.

Tao Qi1, Debbie L Hay.   

Abstract

The receptor activity-modifying proteins (RAMPs) are a family of three single transmembrane proteins that have been identified as accessory proteins to some G-protein-coupled receptors (GPCRs). They can regulate their pharmacology, forward trafficking and recycling, depending on the GPCR. The best characterized receptor complexes formed by RAMPs and GPCRs are the calcitonin peptide family receptors. The association of RAMP1 with the calcitonin receptor-like receptor (CL) constitutes the calcitonin gene-related peptide receptor, whereas RAMP2 or 3 with CL generates adrenomedullin receptors. In this case, the RAMPs substantially alter the pharmacology and trafficking properties of this GPCR. Amylin receptor subtypes are formed from calcitonin receptor (CTR) interactions with RAMPs. Although the RAMPs themselves are not responsive to calcitonin peptide family ligands, there is clear evidence that they participate in ligand binding, although it is still unclear whether this is by directly participating in binding or through allosteric modulation of CL or CTR. A considerable amount of mutagenesis data have now been generated on RAMPs to try and identify the residues that play a role in ligand interactions, and to also identify which residues in RAMPs interact with CL and CTR. This review will focus on RAMP mutagenesis studies with CL, summarizing and discussing the available data in association with current RAMP models and structures. The data reveal key regions in RAMPs that are important for ligand binding and receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015292      PMCID: PMC2839264          DOI: 10.1111/j.1476-5381.2009.00541.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Receptor activity modifying proteins.

Authors:  P M Sexton; A Albiston; M Morfis; N Tilakaratne
Journal:  Cell Signal       Date:  2001-02       Impact factor: 4.315

2.  Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.

Authors:  Jennifer M Bomberger; Narayanan Parameswaran; Carolyn S Hall; Nambi Aiyar; William S Spielman
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

3.  A critical role for the short intracellular C terminus in receptor activity-modifying protein function.

Authors:  Madhara Udawela; George Christopoulos; Maria Morfis; Arthur Christopoulos; Siying Ye; Nanda Tilakaratne; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2006-08-15       Impact factor: 4.436

4.  Sequence analysis of the Receptor Activity-Modifying Proteins family, new putative peptides and structural conformation inference.

Authors:  Alfonso Benítez-Páez
Journal:  In Silico Biol       Date:  2006

5.  Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.

Authors:  Debbie L Hay; George Christopoulos; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2006-09-07       Impact factor: 4.436

6.  Rat RAMP domains involved in adrenomedullin binding specificity.

Authors:  Kenji Kuwasako; Kazuo Kitamura; Hisamitsu Onitsuka; Tomohiko Uemura; Yasuko Nagoshi; Johji Kato; Tanenao Eto
Journal:  FEBS Lett       Date:  2002-05-22       Impact factor: 4.124

7.  The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.

Authors:  Sarah Steiner; Roman Muff; Remo Gujer; Jan A Fischer; Walter Born
Journal:  Biochemistry       Date:  2002-09-24       Impact factor: 3.162

8.  The function of extracellular cysteines in the human adrenomedullin receptor.

Authors:  Kenji Kuwasako; Kazuo Kitamura; Tomohiko Uemura; Yasuko Nagoshi; Johji Kato; Tanenao Eto
Journal:  Hypertens Res       Date:  2003-02       Impact factor: 3.872

9.  Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Ryogo Akasaka; Mitsutoshi Toyama; Takaho Terada; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

10.  Dissection of functional residues in receptor activity-modifying proteins through phylogenetic and statistical analyses.

Authors:  Alfonso Benítez-Páez; Sonia Cárdenas-Brito
Journal:  Evol Bioinform Online       Date:  2008-04-28       Impact factor: 1.625

View more
  14 in total

1.  The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.

Authors:  Kenji Kuwasako; Debbie L Hay; Sayaka Nagata; Tomomi Hikosaka; Kazuo Kitamura; Johji Kato
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Molecular pharmacology of G protein-coupled receptors. Editorial.

Authors:  R J Summers
Journal:  Br J Pharmacol       Date:  2010-03       Impact factor: 8.739

Review 3.  Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Authors:  Song-Yang Zhang; Ming-Jiang Xu; Xian Wang
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

4.  Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.

Authors:  Heather E Moad; Augen A Pioszak
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

5.  Identification of key residues involved in adrenomedullin binding to the AM1 receptor.

Authors:  H A Watkins; M Au; R Bobby; J K Archbold; N Abdul-Manan; J M Moore; M J Middleditch; G M Williams; M A Brimble; A J Dingley; D L Hay
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 6.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

7.  Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization.

Authors:  Christopher F MacManus; Eric L Campbell; Simon Keely; Adrianne Burgess; Douglas J Kominsky; Sean P Colgan
Journal:  FASEB J       Date:  2011-02-24       Impact factor: 5.191

8.  Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.

Authors:  Toshio Sekiguchi; Kenji Kuwasako; Michio Ogasawara; Hiroki Takahashi; Shin Matsubara; Tomohiro Osugi; Ikunobu Muramatsu; Yuichi Sasayama; Nobuo Suzuki; Honoo Satake
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

9.  Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.

Authors:  Jason M Booe; Christopher S Walker; James Barwell; Gabriel Kuteyi; John Simms; Muhammad A Jamaluddin; Margaret L Warner; Roslyn M Bill; Paul W Harris; Margaret A Brimble; David R Poyner; Debbie L Hay; Augen A Pioszak
Journal:  Mol Cell       Date:  2015-05-14       Impact factor: 17.970

10.  The GPS motif is a molecular switch for bimodal activities of adhesion class G protein-coupled receptors.

Authors:  Simone Prömel; Marie Frickenhaus; Samantha Hughes; Lamia Mestek; David Staunton; Alison Woollard; Ioannis Vakonakis; Torsten Schöneberg; Ralf Schnabel; Andreas P Russ; Tobias Langenhan
Journal:  Cell Rep       Date:  2012-08-02       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.